Article
Glucose-6-phosphate dehydrogenase (G6PD)-deficient infants: Enzyme activity and gene variants as risk factors for phototherapy in the first week of life.
Journal of paediatrics and child health - 1 Jul 2017
Wong Fei-Liang, Ithnin Azlin, Othman Ainoon, Cheah Fook-Choe
Abstract excerpt
AIM: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a recognised cause of severe neonatal hyperbilirubinaemia, and identifying which infants are at risk could optimise care and resources. In this study, we determined if G6PD enzyme activity (EA) and certain gene variants were associated with neonatal hyperbilirubinaemia requiring phototherapy during the first week after birth. METHODS: Newborn infants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
